1. Terry Fox Laboratory, British Columbia Cancer Agency and University of British Columbia, Vancouver, BC, Canada;
2. Laboratoire d’Hématologie, Hôpital Paul Brousse, Assistance Publique des Hôpitaux de Paris, INSERM U935, Villejuif, France;
3. School of Pathology and Laboratory Medicine, The University of Western Australia, Crawley WA, Australia;
4. Department of Pathology and Molecular Medicine, McMaster University Medical Centre, Hamilton, ON, Canada;
5. Knight Cancer Institute, Oregon Health & Science University, Portland, OR; and
6. Fred Hutchinson Cancer Research Center, Seattle, WA